All AbMole products are for research use only, cannot be used for human consumption.
Atomoxetine is a selective norepinephrine (NE) transporter inhibitor with Ki of 5 nM, with 15- and 290-fold lower affinity for human 5-HT and DA transporters.
 . figure 6.jpg) |
Source | Cephalalgia (2017) . Figure 6. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | Right, but not left, CeA injection of the KOR agonist produced allodynia in sumatriptan-primed rats. |
 . figure 4.jpg) |
Source | Cephalalgia (2017) . Figure 4. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | Nor-BNI administration into the right, but not left, CeA blocked BLS-induced allodynia. |
 . figure 3.jpg) |
Source | Cephalalgia (2017) . Figure 3. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | BLS increases dynorphin content and pKOR expression in the central nucleus of amygdala (CeA). |
 . figure 2.jpg) |
Source | Cephalalgia (2017) . Figure 2. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | Oral CYM51317 administration before BLS prevented cephalic and extracephalic cutaneous allodynia. |
 . figure 1.jpg) |
Source | Cephalalgia (2017) . Figure 1. Sumatriptan (Abmole Bioscience, Houston, TX, USA) |
| Method | s.c. with osmotic minipump | |
| Cell Lines | Adult male Sprague-Dawley rats | |
| Concentrations | 0.6 mg/kg/day | |
| Incubation Time | 7 days | |
| Results | Systemic KOR antagonist nor-BNI prevented stress-induced cephalic and extracephalic allodynia. Systemic KOR antagonist nor-BNI blocked stress-induced increase in plasma CGRP. |
| Molecular Weight | 291.82 |
| Formula | C17H21NO.HCl |
| CAS Number | 82248-59-7 |
| Solubility (25°C) | DMSO 40 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Samuele Cortese. Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder
| Related 5-HT Receptor Products |
|---|
| Tegaserod
Tegaserod is an orally active serotonin receptor 4 (5-HT4R) agonist and a 5-HT2B receptor antagonist. Tegaserod has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. Tegaserod causes tumor cell apoptosis, blunts PI3K/Akt/mTOR signaling and decreases S6 phosphorylation. |
| cis-Urocanic acid
cis-Urocanic acid is a 5-HT2A receptor agonist. cis-Urocanic acid binds to 5-HT receptor with relatively high affinity (Kd=4.6 nM). cis-Urocanic acid is also an immune modulator that induces immunosuppression. |
| 5-HT2B antagonist-1
5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC50 value of 33.4 nM. |
| AS19
AS19 is a potent, selective 5-HT7 receptor agonist with an IC50 value of 0.83 nM and a Ki of 0.6 nM. |
| CP94253
CP94253 is a selective, orally active agonist for serotonin receptor 1B (5-HT1B), through competitive binding with iodocyanopindolol (ICP) to the 5-HT1 receptor. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
